62791-48-4 Usage
Structure
1-Hydroxy-1-methylcycloheptane-1-carboxylic acid
The structure of this compound is characterized by a cycloheptane ring with a hydroxyl group and a methyl ester group attached to the first carbon.
Type of compound
Organic compound
This compound is classified as an organic compound because it is primarily composed of carbon, hydrogen, and oxygen atoms.
Physical state
Colorless liquid
1-Hydroxy-cycloheptanecarboxylic acid methyl ester is a colorless liquid, which means it does not have a distinct color and flows like a liquid at room temperature.
Odor
Faint
This chemical has a faint odor, which means it has a very subtle or barely noticeable smell.
Solubility
Insoluble in water, soluble in organic solvents
1-Hydroxy-cycloheptanecarboxylic acid methyl ester does not dissolve well in water but dissolves easily in organic solvents, such as alcohols, ethers, and hydrocarbons.
Uses
Synthesis of pharmaceuticals and other organic compounds
This chemical is commonly used as a building block or reagent in the synthesis of various pharmaceuticals and other organic compounds, making it an important intermediate in chemical research and production.
Additional applications
Fragrance and flavor applications
1-Hydroxy-cycloheptanecarboxylic acid methyl ester can also be found in some fragrance and flavor applications, indicating that it may have properties that contribute to pleasant scents or tastes.
Check Digit Verification of cas no
The CAS Registry Mumber 62791-48-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,7,9 and 1 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 62791-48:
(7*6)+(6*2)+(5*7)+(4*9)+(3*1)+(2*4)+(1*8)=144
144 % 10 = 4
So 62791-48-4 is a valid CAS Registry Number.
62791-48-4Relevant articles and documents
BENZAMIDINE DERIVATIVES SUBSTITUTED BY CYCLIC AMINO ACID AND CYCLIC HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS
-
, (2008/06/13)
This invention is directed to benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
